Menu

Infographic: Dialing Up Dopamine

Synaptic vesicles can dynamically adjust neurotransmitter content in response to neuronal firing.

Oct 31, 2017
Catherine Offord
© EVAN OTO/SCIENCE SOURCE
Researchers have found that synaptic vesicles releasing dopamine across neuronal synapses in fruit flies and mice can dynamically adjust the neurotransmitter content in response to neuronal firing. And they propose a mechanism to explain how. When the axon terminal depolarizes, sodium ions flow into the cell (1). The increased sodium ion concentration activates sodium-hydrogen exchangers in the vesicle membrane that transport one sodium ion into the vesicle for every proton out (2). This action increases the difference in electrical charge across the vesicle membrane, activating a transporter protein, VGLUT, which pumps another neurotransmitter, negatively charged glutamate, into the vesicle (3). The resulting buildup of internal negative charge triggers the pumping of more protons into the vesicle, increasing the pH gradient across the membrane (4). Finally, this drop in pH inside the vesicle triggers the loading of more dopamine into the vesicles via the VMAT protein (5).
 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.